SEC v. Robert Alan Yedid; Andrew Kaufman; and Mark Jacobs, No. LR-26376, Southern District of New York (Aug. 18, 2025) — Press Release
raw: Robert Alan Yedid, Andrew Kaufman, Mark Jacobs
Robert Alan Yedid, Andrew Kaufman, Mark Jacobs, No. 1:25-CV-06704 (S.D.N.Y. Aug. 18, 2025)
Robert Yedid, Andrew Kaufman, and Mark Jacobs were charged by the SEC for insider trading that generated over $500,000 in profits, resulting in permanent injunctions and professional bars.
The SEC charged Robert Yedid, Andrew Kaufman, and Mark Jacobs with violating Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5. The scheme involved over $500,000 in combined illegal profits derived from trading on nonpublic pharmaceutical and biotechnology data. All three defendants consented to permanent injunctions, while Yedid also received bars from serving as a public company officer or director and associating with a broker-dealer.
The SEC charged former investor relations executive Robert Yedid and his friends, Andrew Kaufman and Mark Jacobs, with insider trading spanning from 2019 to 2024. As a managing director at a consulting firm, Yedid provided material nonpublic information regarding pharmaceutical clients—including drug test results and pending mergers—to Kaufman and Jacobs. This information allowed them to trade in at least six public companies, generating more than $500,000 in illegal profits. In return for the tips, Kaufman allegedly provided Yedid with payments in envelopes of cash. The defendants face charges for violating Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5. All three parties consented to permanent injunctions against future violations, with the court to later determine specific disgorgement and penalties. Additionally, Yedid consented to a conduct-based injunction barring him from serving as a public company officer or director and from associating with a broker-dealer.
Exhibits & Attached Documents (1)
Extracted insights
- $500K $500,000 $100K–$1M
- person andrew kaufman
- person robert alan yedid
- agency Securities and Exchange Commission
- Securities And Exchange Commission charged Robert Alan Yedid and his long-time friends, Andrew Kaufman and Mark Jacobs, with insider trading that resulted in more than $500,000 in combined illegal profits
- Robert Alan Yedid provided material nonpublic information about the firm’s clients—including drug test results, financial and regulatory information, and pending mergers and acquisitions—to Andrew Kaufman and Mark Jacobs
- Andrew Kaufman and Mark Jacobs traded in the securities of as many as six public companies based on material nonpublic information provided by Robert Alan Yedid
- Andrew Kaufman shared his illicit proceeds with Robert Alan Yedid by handing him envelopes of cash
- Securities And Exchange Commission charges Robert Alan Yedid, Andrew Kaufman, and Mark Jacobs with violating the antifraud provisions of Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder
- Robert Alan Yedid consented to a conduct-based injunction barring him from associating with a broker or dealer, and a bar preventing him from serving as an officer or director of a public company
- Robert Alan Yedid, Andrew Kaufman, and Mark Jacobs consented to the entry of an order permanently enjoining them from violating the charged provisions and authorizing the court to determine at a later date the amount of disgorgement, prejudgment interest, and civil money penalties that each defendant shall pay
- Securities And Exchange Commission appreciates the assistance of the Financial Industry Regulatory Authority, the FBI, and the U.S. Attorney’s Office for the Southern District of New York
U.S. SECURITIES AND EXCHANGE COMMISSION Litigation Release No. LR-26376 / August 18, 2025 Securities and Exchange Commission v. Robert Yedid, Andrew Kaufman, and Mark Jacobs, No. 1:25-CV-06704 (S.D.N.Y. filed Aug. 14, 2025) SEC Charges Former Investor Relations Executive and Two Friends with Insider Trading On August 14, 2025, the Securities and Exchange Commission charged Robert Alan Yedid and his long-time friends, Andrew Kaufman and Mark Jacobs, with insider trading that resulted in more than $500,000 in combined illegal profits. The SEC’s complaint alleges that Kaufman and Jacobs traded in the securities of as many as six public companies based on material nonpublic information provided by Yedid from at least 2019 through 2024. As alleged, during that time, Yedid was a managing director at a consulting firm that assists pharmaceutical and biotechnology companies with investor communications. In that role, according to the complaint, Yedid obtained material nonpublic information about the firm’s clients—including drug test results, financial and regulatory information, and pending mergers and acquisitions—that he repeatedly shared with Kaufman and Jacobs, who then engaged in lucrative insider trading. As alleged, Kaufman shared his illicit proceeds with Yedid by handing him envelopes of cash. The complaint, filed in the U.S. District Court for the Southern District of New York, charges Yedid, Kaufman, and Jacobs with violating the antifraud provisions of Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder. Yedid, Kaufman, and Jacobs each consented to the entry of an order permanently enjoining them from violating the charged provisions and authorizing the court to determine at a later date the amount of disgorgement, prejudgment interest, and civil money penalties that each defendant shall pay. Yedid also consented to a conduct-based injunction barring him from associating with a broker or dealer, and a bar preventing him from serving as an officer or director of a public company. The SEC's investigation was conducted by Jason Anthony, Nancy C. Iheanacho, and Margaret Vizzi, and supervised by Paul H. Pashkoff and Pei Y. Chung, all of the SEC’s Home Office. The litigation will be led by Daniel Maher and supervised by David A. Nasse of the SEC’s Home Office. The SEC appreciates the assistance of the Financial Industry Regulatory Authority, the FBI, and the U.S. Attorney’s Office for the Southern District of New York.
U.S. SECURITIES AND EXCHANGE COMMISSION Litigation Release No. LR-26376 / August 18, 2025 Securities and Exchange Commission v. Robert Yedid, Andrew Kaufman, and Mark Jacobs, No. 1:25-CV-06704 (S.D.N.Y. filed Aug. 14, 2025) SEC Charges Former Investor Relations Executive and Two Friends with Insider Trading On August 14, 2025, the Securities and Exchange Commission charged Robert Alan Yedid and his long-time friends, Andrew Kaufman and Mark Jacobs, with insider trading that resulted in more than $500,000 in combined illegal profits. The SEC’s complaint alleges that Kaufman and Jacobs traded in the securities of as many as six public companies based on material nonpublic information provided by Yedid from at least 2019 through 2024. As alleged, during that time, Yedid was a managing director at a consulting firm that assists pharmaceutical and biotechnology companies with investor communications. In that role, according to the complaint, Yedid obtained material nonpublic information about the firm’s clients—including drug test results, financial and regulatory information, and pending mergers and acquisitions—that he repeatedly shared with Kaufman and Jacobs, who then engaged in lucrative insider trading. As alleged, Kaufman shared his illicit proceeds with Yedid by handing him envelopes of cash. The complaint, filed in the U.S. District Court for the Southern District of New York, charges Yedid, Kaufman, and Jacobs with violating the antifraud provisions of Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder. Yedid, Kaufman, and Jacobs each consented to the entry of an order permanently enjoining them from violating the charged provisions and authorizing the court to determine at a later date the amount of disgorgement, prejudgment interest, and civil money penalties that each defendant shall pay. Yedid also consented to a conduct-based injunction barring him from associating with a broker or dealer, and a bar preventing him from serving as an officer or director of a public company. The SEC's investigation was conducted by Jason Anthony, Nancy C. Iheanacho, and Margaret Vizzi, and supervised by Paul H. Pashkoff and Pei Y. Chung, all of the SEC’s Home Office. The litigation will be led by Daniel Maher and supervised by David A. Nasse of the SEC’s Home Office. The SEC appreciates the assistance of the Financial Industry Regulatory Authority, the FBI, and the U.S. Attorney’s Office for the Southern District of New York.